PrNMI’s Two-Week Rat Result Was a Compound-Specific Cannabinoid Tolerance Finding

Illustration of a printed chromatogram beside a sample vial and pen

PrNMI maintained pain-related efficacy during two weeks of treatment in a rat chemotherapy-neuropathy model. That finding concerns one experimental cannabinoid and regimen, rather than proving that cannabis analgesia generally remains unchanged with repeated use.

The study targeted peripheral CB1 receptors

Researchers tested the synthetic, peripherally restricted agonist PrNMI in cisplatin-treated rats. Local, systemic and oral administration reduced mechanical and cold hypersensitivity. Receptor-blocking experiments supported CB1 involvement. Tissue assays examined sensory-ganglion receptor expression.

The positive result had defined boundaries

Daily treatment did not produce appreciable loss of anti-allodynic effect over the observed two weeks. Oral dosing showed similar potency and efficacy between males and females. The study also included an operant pain-related task, extending its observations beyond withdrawal reflexes alone.

Absence of detected tolerance was not lifelong stability

Two weeks of repeated dosing cannot establish that tolerance never develops, or that longer exposure would have the same profile. The investigators also noted that effectiveness in other chemotherapy-neuropathy models required investigation. A cisplatin model is not interchangeable with every source of neuropathic pain.

Keep chemistry, function and species separate

The selected central-effect assessments were favorable at the tested conditions, but they were not human driving or cognitive examinations. PrNMI is not THC and was not a retail cannabis preparation. The paper provides evidence for further development of a particular peripheral-cannabinoid strategy; it does not establish a safe human dose, an impairment-free interval or a general exemption from cannabis tolerance.

Related analysis: Cannabis Tolerance Claims: Questions to Ask Before Relying on Expert Testimony.

Primary research

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation. Neuropharmacology (2018). DOI: 10.1016/j.neuropharm.2018.07.002.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Why Clothing Belongs in a Body Temperature Record

Saukko and Knight describe clothing and coverings as factors that affect heat exchange after death.

Spread the love

Read Article: Why Clothing Belongs in a Body Temperature Record

How Decomposition Can Produce Blisters and Skin Slippage

Blisters and areas of loose skin can develop during decomposition.

Spread the love

Read Article: How Decomposition Can Produce Blisters and Skin Slippage

Why Pale Areas Can Appear Within Postmortem Lividity

After death, blood settles in dependent areas and may produce a visible discoloration called lividity.

Spread the love

Read Article: Why Pale Areas Can Appear Within Postmortem Lividity

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us